Search
Allogene Therapeutics Inc
ALLOAdd to Watchlist
1.670USD
0.0000.00%
Close 09-24 16:00（ET）
576.40MMarket Cap
LossP/E TTM
After-hours 19:34 (ET)1.720USD+0.050+2.99%
After-hours 19:34 (ET)ALLO Financials
See Allogene Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
576.40M
Dividend TTM
0.00
P/E TTM
-2.18
EPS TTM
-0.77
Revenue
0.00
Net Profit
-257.59M
ROE
-52.32%
ROA
-38.45%
Allogene Therapeutics Inc Earnings Date
Latest Release
Aug 12, 2026
EPS / Forecast
-0.13/-0.17
Revenue / Forecast
4.64M/2.22K
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its current assets were 257.75M, with a year-on-year change of -15.04.
What are the total assets of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total assets of Allogene Therapeutics Inc were 415.90M, with a year-on-year change of -24.20.
What are the total liabilities of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total liabilities of Allogene Therapeutics Inc were 123.36M, with a year-on-year change of -2.50.
What is the total equity of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its total equity of Allogene Therapeutics Inc was 292.54M, with a year-on-year change of -30.71.
What is the net operating income of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net operating income of Allogene Therapeutics Inc was -206.93M, with a year-on-year change of 19.63.
What is the net investment of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net investment of Allogene Therapeutics Inc was 95.56M, with a year-on-year change of 26.25.
What is the net financing of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net financing of Allogene Therapeutics Inc was 30.16M, with a year-on-year change of -74.15.
What is the Earnings Per Share (EPS) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.87, with a year-on-year change of 34.57.
What is the net income of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its net income was -190.89M, with a year-on-year change of 25.90.
What is the Return on Equity (ROE) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -53.42, with a year-on-year change of 3.12.
What is the Return on Assets (ROA) of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -39.58, with a year-on-year change of 8.46.
What is the operating profit of Allogene Therapeutics Inc?
According to Allogene Therapeutics Inc's FY2025 earnings report, its operating profit was -206.93M, with a year-on-year change of 19.63.